Using National Databases for Research: The Good and the Bad
The NIS and NRD offer convenient data sources for fellows starting out in research—just don’t overlook other opportunities.
Related Articles
Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help
There remains an unmet need for therapies proven to lower the increased CV risk seen in this population.
CALORI: More Support for Eschewing Fasting Protocols Preprocedure
Compared with patients who fasted, those who didn’t reported a better overall experience with zero safety compromises.
AI in Heart Failure
Jagmeet Singh joins Harriette Van Spall to discuss artificial intelligence in the realm of heart failure.
After DanGer Shock’s Win in AMICS for Impella: What’s Next?
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
Statins Might Help in HFpEF—Even in the Absence of ASCVD
Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.
TCTMD’s Quick Takes: Dr. Monika Safford
Monika Safford, MD, explains how peer coaching and practice facilitation may improve systolic blood pressure for patients in the US “Black Belt.”
The SELECT Trial
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.